Evaluation of Clinical Efficacy of Autologous Adipose Tissue Derived ADSCSs in Treatment of Osteoarthritis (OA)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

May 16, 2016

Primary Completion Date

June 27, 2020

Study Completion Date

February 25, 2021

Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL

Autologous adipose tissue derived stromal cells

autologous adipose tissue derived stromal cells is recovered as pellet after non enzymatic processing with sonication using ultrasound . This isolation process yielded an abundant population of Adipose stromal cells(ASCs) which have multipotent differentiation potential. Immunophenotype is a CD14-, CD29+, CD31-, CD34low/+, CD45-, CD73+ and CD105+ , the SVF represents the 50-70% in volume of a lipoaspirate specimen. The SVF hosts a heterogeneous cell population (110x103 cells/ml on average) comprising mainly CD105+ mesenchymal stem cells (MSC,2-- 20%), plus a wide number of CD34+ hematopoietic cells (40%)

Trial Locations (1)

263153

Anupam Hospital, Rudrapur

All Listed Sponsors
lead

Dr. Himanshu Bansal Foundation

OTHER

NCT05484856 - Evaluation of Clinical Efficacy of Autologous Adipose Tissue Derived ADSCSs in Treatment of Osteoarthritis (OA) | Biotech Hunter | Biotech Hunter